Susan G. Komen recently announced new advisory roles for 12 leaders in breast cancer. These women and men will join an esteemed group of breast cancer researchers, clinicians, and advocates who help guide the organization’s education and advocacy work, public health efforts, and research programs.
Lisa Carey, MD
Sandy Finestone, PsyD
Lisa Carey, MD, of the University of North Carolina’s Lineberger Comprehensive Cancer Center, and Sandy Finestone, PsyD, a Komen Advocate in Science from Costa Mesa, California, became the two newest members of Komen’s Scientific Advisory Board. As global leaders of research, clinical practice, and patient advocacy, members of Komen’s Scientific Advisory Board help guide the organization’s research programs and priorities.
Newest Komen Scholars
Susan G. Komen also welcomes 10 new members as Komen Scholars, an advisory group of leaders in breast cancer research and advocacy.
- Wayne Dornan, PhD, Advocates in Science Steering Committee, -Smyrna, Tennessee
- Reshma Jagsi, MD, DPhil, University of Michigan, Ann Arbor, Michigan
- Marian Johnson-Thompson, PhD, Advocates in Science Steering Committee, Durham, North Carolina
- Ingrid Mayer, MD, MSci, Vanderbilt University Medical Center, Nashville
- Donald McDonnell, PhD, Duke University School of Medicine, Durham, North Carolina
- Julie Palmer, ScD, MPH, Boston University, Boston
- Amelie Ramirez, DrPH, The University of Texas Health Science Center, San Antonio, Texas
- Rebecca Seago-Coyle, MA, Advocates in Science Steering Committee, Rochester, Washington
- Sohrab Shah, PhD, Memorial Sloan Kettering Cancer Center, New York
- Meryl Weinreb, MA, Advocates in Science Steering Committee, Landenberg, Pennsylvania.
